Cellid

Search results

Bio & Pharma Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

May 23, 2023 (Gmt+09:00)
Bio & Pharma Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

Feb 15, 2023 (Gmt+09:00)

Cookies on KED Global

We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.

Cookies on KED Global Sites

THE KOREA ECONOMIC DAILY, GLOBAL EDITION

SIGN IN
JOIN

Companies
Korean Investors
- Korean Investors Home
- Best Asset Managers by Korean Investors
Deals
- M&A
- ECM/DCM
Markets
Culture & Trends
Perspectives
Hidden Champions
Future Unicorns

Follow us

Cellid

Cookies on KED Global

No articles were found.Please search again.

No articles were found.
Please search again.